null

SMILES: CC(C)[C@@H]1N(Cc2ccc(cc2)C(F)(F)F)Cc2cc(cnc12)C(=O)N[C@@H](CO)c1ccc(cc1)C#N

InChI Key: InChIKey=ZJJYLEWSVPCEGR-AHWVRZQESA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 317996   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317996 (US10399976, Compound 149 | US10807980, Compound 14...) Show SMILES CC(C)[C@@H]1N(Cc2ccc(cc2)C(F)(F)F)Cc2cc(cnc12)C(=O)N[C@@H](CO)c1ccc(cc1)C#N |r| Show InChI InChI=1S/C28H27F3N4O2/c1-17(2)26-25-22(15-35(26)14-19-5-9-23(10-6-19)28(29,30)31)11-21(13-33-25)27(37)34-24(16-36)20-7-3-18(12-32)4-8-20/h3-11,13,17,24,26,36H,14-16H2,1-2H3,(H,34,37)/t24-,26-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the present invention were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-li...				US Patent US9624217 (2017) BindingDB Entry DOI: 10.7270/Q29P33RJ
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317996 (US10399976, Compound 149 | US10807980, Compound 14...) Show SMILES CC(C)[C@@H]1N(Cc2ccc(cc2)C(F)(F)F)Cc2cc(cnc12)C(=O)N[C@@H](CO)c1ccc(cc1)C#N |r| Show InChI InChI=1S/C28H27F3N4O2/c1-17(2)26-25-22(15-35(26)14-19-5-9-23(10-6-19)28(29,30)31)11-21(13-33-25)27(37)34-24(16-36)20-7-3-18(12-32)4-8-20/h3-11,13,17,24,26,36H,14-16H2,1-2H3,(H,34,37)/t24-,26-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for ability to bind to ROR gamma in a cell-free competition assay with commercially available radio-li...				US Patent US10399976 (2019) BindingDB Entry DOI: 10.7270/Q2F76FXT
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317996 (US10399976, Compound 149 | US10807980, Compound 14...) Show SMILES CC(C)[C@@H]1N(Cc2ccc(cc2)C(F)(F)F)Cc2cc(cnc12)C(=O)N[C@@H](CO)c1ccc(cc1)C#N |r| Show InChI InChI=1S/C28H27F3N4O2/c1-17(2)26-25-22(15-35(26)14-19-5-9-23(10-6-19)28(29,30)31)11-21(13-33-25)27(37)34-24(16-36)20-7-3-18(12-32)4-8-20/h3-11,13,17,24,26,36H,14-16H2,1-2H3,(H,34,37)/t24-,26-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Compounds of the present invention were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-li...				Citation and Details BindingDB Entry DOI: 10.7270/Q2BK1H79
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317996 (US10399976, Compound 149 | US10807980, Compound 14...) Show SMILES CC(C)[C@@H]1N(Cc2ccc(cc2)C(F)(F)F)Cc2cc(cnc12)C(=O)N[C@@H](CO)c1ccc(cc1)C#N |r| Show InChI InChI=1S/C28H27F3N4O2/c1-17(2)26-25-22(15-35(26)14-19-5-9-23(10-6-19)28(29,30)31)11-21(13-33-25)27(37)34-24(16-36)20-7-3-18(12-32)4-8-20/h3-11,13,17,24,26,36H,14-16H2,1-2H3,(H,34,37)/t24-,26-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-li...				US Patent US10807980 (2020) BindingDB Entry DOI: 10.7270/Q2PR803S
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317996 (US10399976, Compound 149 | US10807980, Compound 14...) Show SMILES CC(C)[C@@H]1N(Cc2ccc(cc2)C(F)(F)F)Cc2cc(cnc12)C(=O)N[C@@H](CO)c1ccc(cc1)C#N |r| Show InChI InChI=1S/C28H27F3N4O2/c1-17(2)26-25-22(15-35(26)14-19-5-9-23(10-6-19)28(29,30)31)11-21(13-33-25)27(37)34-24(16-36)20-7-3-18(12-32)4-8-20/h3-11,13,17,24,26,36H,14-16H2,1-2H3,(H,34,37)/t24-,26-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for RORγ inverse agonist activity in a cell-based, transcriptional activity assay. Secreted Nanol...				US Patent US10807980 (2020) BindingDB Entry DOI: 10.7270/Q2PR803S
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317996 (US10399976, Compound 149 | US10807980, Compound 14...) Show SMILES CC(C)[C@@H]1N(Cc2ccc(cc2)C(F)(F)F)Cc2cc(cnc12)C(=O)N[C@@H](CO)c1ccc(cc1)C#N |r| Show InChI InChI=1S/C28H27F3N4O2/c1-17(2)26-25-22(15-35(26)14-19-5-9-23(10-6-19)28(29,30)31)11-21(13-33-25)27(37)34-24(16-36)20-7-3-18(12-32)4-8-20/h3-11,13,17,24,26,36H,14-16H2,1-2H3,(H,34,37)/t24-,26-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for ROR gamma inverse agonist activity in a cell-based, transcriptional activity assay. Secreted Nanol...				US Patent US10399976 (2019) BindingDB Entry DOI: 10.7270/Q2F76FXT
					More data for this Ligand-Target Pair